Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
210.9 USD | -0.75% | -0.99% | +0.16% |
26/04 | Wall Street: the worst week of 2024 is followed by the best | CF |
26/04 | US Equity Indexes Advance This Week as Fed's Preferred Measure of Inflation Meets Expectations | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.16% | 75.94B | B | ||
+12.06% | 21.7B | C+ | ||
+27.19% | 12.54B | C+ | ||
+39.83% | 8.36B | C+ | ||
-0.13% | 7.96B | B- | ||
+44.53% | 5.21B | C | ||
-2.16% | 2.96B | C+ | ||
-5.45% | 1.69B | C | ||
+15.14% | 1.29B | - | ||
+74.10% | 1.28B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CME Stock
- Ratings CME Group Inc.